← Back to Patent Explorer
US4965195A Expired / Lapsed US ⏱️ 0.0 years remaining

Interleukin-7

Assignee: Sanofi Aventis France
•
Filing: 1988-10-07
•
Granted: 1990-10-23
•
Expires: 2008-10-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Mammalian Interleukin-7 proteins (IL-7s), DNAs and expression vectors encoding mammalian IL-7s, and processes for producing mammalian IL-7s as products of cell culture, including recombinant systems, are disclosed.

Inventors

  • 👤 Anthony E. Namen
  • 👤 Raymond G. Goodwin
  • 👤 Stephen D. Lupton
  • 👤 Diane Y. Mochizuki

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 19:33
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/80; C12N15/81; C07; C07K; C07K14/00; C07K14/435; C07K14/52; C07K14/54; C07K14/5418; C07K16/00; C07K16/18; C07K16/24; C07K16/244; C12N15/11; C12N15/62; C12N15/625; C12N15/70; C12N15/85; A; A61; A61K; A61K38/00; C07K2317/00; C07K2317/30; C07K2317/34; C07K2319/00; C07K2319/01; C07K2319/036; C07K2319/40; C07K2319/43; C07K2319/50; C07K2319/70; C07K2319/74; C07K2319/75

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 47 words
An isolated and purified double-stranded DNA molecule encoding a polypeptide displaying interleukin 7 biological activity, wherein (A) one DNA strand of said molecule hybridizes to a labeled oligonucleotide probe, under hybridization conditions of 50° C. and 0.9 M NaCl, followed by washing in 1×SSC at 55° C.
Claim 2
Dependent Claim 47 words
An isolated and purified double-stranded DNA molecule encoding a polypeptide displaying interleukin 7 biological activity, wherein (A) one DNA strand of said molecule hybridizes to a labeled oligonucleotide probe, under hybridization conditions of 50° C. and 0.9 M NaCl, followed by washing in 1×SSC at 55° C.
Claim 3
Dependent Claim 21 words
An isolated and purified DNA molecule according to claim 1, said molecule encoding a biologically active murine IL-7 or IL-7 mutein.
Claim 4
Dependent Claim 24 words
An isolated and purified DNA molecule according to claim 2, which encodes a polypeptide having the amino-acid sequence of residues 1-129 in FIG. 3.
Claim 5
Dependent Claim 21 words
An isolated and purified DNA molecule according to claim 1, said molecule encoding a biologically active human IL-7 or IL-7 mutein.
Claim 6
Dependent Claim 24 words
An isolated and purified DNA molecule according to claim 4, which encodes a polypeptide having the amino-acid sequence of residues 1-152 in FIG. 5.
Claim 7
Dependent Claim 12 words
A recombinant expression vector comprising a DNA molecule according to claim 1.
Claim 8
Dependent Claim 12 words
A recombinant expression vector comprising a DNA molecule according to claim 4.
Claim 9
Dependent Claim 12 words
A recombinant expression vector comprising a DNA molecule according to claim 5.
Claim 10
Dependent Claim 50 words
A process for preparing a polypeptide comprising a mammalian IL-7, or IL-7 mutein, said polypeptide displaying IL-7 biological activity, comprising the steps of (a) culturing a host cell comprising a vector according to claim 6, such that said polypeptide is expressed in recoverable amounts; and then (b) recovering said polypeptide.
Claim 11
Dependent Claim 50 words
A process for preparing a polypeptide comprising a mammalian IL-7, or IL-7 mutein, said polypeptide displaying IL-7 biological activity, comprising the steps of (a) culturing a host cell comprising a vector according to claim 7, such that said polypeptide is expressed in recoverable amounts; and then (b) recovering said polypeptide.
Claim 12
Dependent Claim 50 words
A process for preparing a polypeptide comprising a mammalian IL-7, or IL-7 mutein, said polypeptide displaying IL-7 biological activity, comprising the steps of (a) culturing a host cell comprising a vector according to claim 8, such that said polypeptide is expressed in recoverable amounts; and then (b) recovering said polypeptide.
Claim 13
Dependent Claim 59 words
A process according to claim 9, wherein said host cell is of the species E. coli and wherein step (b) comprises (1) harvesting said cells, (2) extracting said cells in a denaturing buffer to obtain a cell extract comprising said polypeptide and (3) rapidly diluting with culture medium said cell extract to produce said polypeptide having said biological activity.
Claim 14
Dependent Claim 59 words
A process according to claim 10, wherein said host cell is of the species E. coli and wherein step (b) comprises (1) harvesting said cells, (2) extracting said cells in a denaturing buffer to obtain a cell extract comprising said polypeptide and (3) rapidly diluting with culture medium said cell extract to produce said polypeptide having said biological activity.
Claim 15
Dependent Claim 59 words
A process according to claim 11, wherein said host cell is of the species E. coli and wherein step (b) comprises (1) harvesting said cells, (2) extracting said cells in a denaturing buffer to obtain a cell extract comprising said polypeptide and (3) rapidly diluting with culture medium said cell extract to produce said polypeptide having said biological activity.
Claim 16
Dependent Claim 38 words
A process according to claim 9, wherein said host cell is a BHK or COS-7 cell and wherein step (b) comprises (1) harvesting a culture supernatant of said host cell comprising said polypeptide and (2) recovering said polypeptide.
Claim 17
Dependent Claim 38 words
A process according to claim 10, wherein said host cell is a BHK or COS-7 cell and wherein step (b) comprises (1) harvesting a culture supernatant of said host cell comprising said polypeptide and (2) recovering said polypeptide.
Claim 18
Dependent Claim 38 words
A process according to claim 11, wherein said host cell is a BHK or COS-7 cell and wherein step (b) comprises (1) harvesting a culture supernatant of said host cell comprising said polypeptide and (2) recovering said polypeptide.

References Cited (Backward Citations)

US4675285A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-10-22 1994-04-23 1994-10-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-10-22 1998-04-23 1998-10-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-10-22 2002-04-23 2002-10-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag